Justices Ask Tough Questions In AIA On-Sale Bar Case

Law360 (December 4, 2018, 8:48 PM EST) -- U.S. Supreme Court justices on Tuesday wrestled with the idea that the America Invents Act may have narrowed the on-sale bar in patent cases, while leaving open the door for a possible exception to the bar for activities that aren’t commercial sales.

The justices peppered both sides with questions in a case that concerns a patent on Helsinn Healthcare SA’s nausea drug Aloxi. The patent, which Helsinn accused Teva Pharmaceuticals USA Inc. of infringing with a planned generic, was invalidated last year by the Federal Circuit.

The on-sale bar holds that sales of an invention that occur more than a year...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!